Haemonetics Stock Price Prediction
| HAE Stock | USD 84.88 0.34 0.40% |
Oversold Vs Overbought
65
Oversold | Overbought |
Haemonetics stock price prediction is an act of determining the future value of Haemonetics shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Haemonetics' future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Haemonetics and does not consider all of the tangible or intangible factors available from Haemonetics' fundamental data. We analyze noise-free headlines and recent hype associated with Haemonetics, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Haemonetics' stock price prediction:Quarterly Earnings Growth (0.05) | EPS Estimate Next Quarter 0.92 | EPS Estimate Current Year 3.96 | EPS Estimate Next Year 4.4 | Wall Street Target Price 105.57 |
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Haemonetics based on different types of headlines from major news networks to social media. The Haemonetics stock price prediction module provides an analysis of price elasticity to changes in media outlook on Haemonetics over a specific investment horizon. Using Haemonetics hype-based prediction, you can estimate the value of Haemonetics from the perspective of Haemonetics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Haemonetics using Haemonetics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Haemonetics using crowd psychology based on the activity and movement of Haemonetics' stock price.
Haemonetics Short Interest
A significant increase or decrease in Haemonetics' short interest from the previous month could be a good indicator of investor sentiment towards Haemonetics. Short interest can provide insight into the potential direction of Haemonetics stock and how bullish or bearish investors feel about the market overall. An investor who is long Haemonetics may also wish to track short interest. As short interest increases, investors should be becoming more worried about Haemonetics and may potentially protect profits, hedge Haemonetics with its derivative instruments, or be ready for some potential downside.
200 Day MA 84.8301 | Short Percent 0.061 | Short Ratio 4.36 | Shares Short Prior Month 2 M | 50 Day MA 78.3004 |
Haemonetics Hype to Price Pattern
Investor biases related to Haemonetics' public news can be used to forecast risks associated with an investment in Haemonetics. The trend in average sentiment can be used to explain how an investor holding Haemonetics can time the market purely based on public headlines and social activities around Haemonetics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Haemonetics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Haemonetics.
Haemonetics Implied Volatility | 50.66 |
Haemonetics' implied volatility exposes the market's sentiment of Haemonetics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Haemonetics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Haemonetics stock will not fluctuate a lot when Haemonetics' options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Haemonetics. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Haemonetics to buy its stock at a price that has no basis in reality. In that case, they are not buying Haemonetics because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.
Haemonetics after-hype prediction price | USD 84.94 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Prediction based on Rule 16 of the current Haemonetics contract
Based on the Rule 16, the options market is currently suggesting that Haemonetics will have an average daily up or down price movement of about 3.17% per day over the life of the 2024-04-19 option contract. With Haemonetics trading at USD 84.88, that is roughly USD 2.69 . If you think that the market is fully incorporating Haemonetics' daily price movement you should consider acquiring Haemonetics options at the current volatility level of 50.66%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Haemonetics |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Haemonetics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Haemonetics After-Hype Price Prediction Density Analysis
As far as predicting the price of Haemonetics at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Haemonetics or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Haemonetics, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Haemonetics Estimiated After-Hype Price Volatility
In the context of predicting Haemonetics' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Haemonetics' historical news coverage. Haemonetics' after-hype downside and upside margins for the prediction period are 83.19 and 86.69, respectively. We have considered Haemonetics' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Haemonetics is very steady at this time. Analysis and calculation of next after-hype price of Haemonetics is based on 3 months time horizon.
Haemonetics Stock Price Prediction Analysis
Have you ever been surprised when a price of a Company such as Haemonetics is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Haemonetics backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Haemonetics, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.06 | 1.74 | 0.06 | 0.01 | 11 Events / Month | 5 Events / Month | In about 11 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | ||
84.88 | 84.94 | 0.07 |
|
Haemonetics Hype Timeline
On the 16th of April 2024 Haemonetics is traded for 84.88. The entity has historical hype elasticity of 0.06, and average elasticity to hype of competition of -0.01. Haemonetics is forecasted to increase in value after the next headline, with the price projected to jump to 84.94 or above. The average volatility of media hype impact on the company the price is about 187.1%. The price growth on the next news is projected to be 0.07%, whereas the daily expected return is currently at 0.06%. The volatility of related hype on Haemonetics is about 1903.12%, with the expected price after the next announcement by competition of 84.87. The company reported the last year's revenue of 1.17 B. Total Income to common stockholders was 115.4 M with profit before taxes, overhead, and interest of 530.77 M. Considering the 90-day investment horizon the next forecasted press release will be in about 11 days. Check out Haemonetics Basic Forecasting Models to cross-verify your projections.Haemonetics Related Hype Analysis
Having access to credible news sources related to Haemonetics' direct competition is more important than ever and may enhance your ability to predict Haemonetics' future price movements. Getting to know how Haemonetics' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Haemonetics may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| ENSG | The Ensign Group | 0.78 | 11 per month | 1.12 | 0 | 2.38 | (2.33) | 7.13 | |
| SEM | Select Medical Holdings | (0.1) | 8 per month | 1.41 | 0.01 | 2.43 | (2.34) | 12.75 | |
| EHC | Encompass Health Corp | (0.71) | 10 per month | 0.70 | 0.14 | 2.76 | (1.43) | 7.95 | |
| EHAB | Enhabit | 0.07 | 7 per month | 2.97 | (0) | 5.48 | (4.79) | 27.98 | |
| PNTG | Pennant Group | (0.05) | 10 per month | 1.56 | 0.16 | 3.45 | (3.21) | 13.54 | |
| NHC | National HealthCare | (0.84) | 10 per month | 0.00 | (0.11) | 2.18 | (2.67) | 7.84 | |
| CCEL | CryoCell International | 0.21 | 2 per month | 2.93 | 0.08 | 7.79 | (6.04) | 23.27 |
Haemonetics Additional Predictive Modules
Most predictive techniques to examine Haemonetics price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Haemonetics using various technical indicators. When you analyze Haemonetics charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
About Haemonetics Predictive Indicators
The successful prediction of Haemonetics stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Haemonetics, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Haemonetics based on analysis of Haemonetics hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Haemonetics's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Haemonetics's related companies. | 2023 | 2024 (projected) | Dividend Yield | 0.008593 | 0.006123 | Price To Sales Ratio | 4.27 | 2.14 |
Story Coverage note for Haemonetics
The number of cover stories for Haemonetics depends on current market conditions and Haemonetics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Haemonetics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Haemonetics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
View All Premium Stories
Haemonetics Short Properties
Haemonetics' future price predictability will typically decrease when Haemonetics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Haemonetics often depends not only on the future outlook of the potential Haemonetics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Haemonetics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 51.4 M | |
| Cash And Short Term Investments | 284.5 M |
Check out Haemonetics Basic Forecasting Models to cross-verify your projections. For information on how to trade Haemonetics Stock refer to our How to Trade Haemonetics Stock guide.Note that the Haemonetics information on this page should be used as a complementary analysis to other Haemonetics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Complementary Tools for Haemonetics Stock analysis
When running Haemonetics' price analysis, check to measure Haemonetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Haemonetics is operating at the current time. Most of Haemonetics' value examination focuses on studying past and present price action to predict the probability of Haemonetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Haemonetics' price. Additionally, you may evaluate how the addition of Haemonetics to your portfolios can decrease your overall portfolio volatility.
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Bond Analysis Evaluate and analyze corporate bonds as a potential investment for your portfolios. | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios |
Is Haemonetics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Haemonetics. If investors know Haemonetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Haemonetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.05) | Earnings Share 2.46 | Revenue Per Share 25.092 | Quarterly Revenue Growth 0.101 | Return On Assets 0.0612 |
The market value of Haemonetics is measured differently than its book value, which is the value of Haemonetics that is recorded on the company's balance sheet. Investors also form their own opinion of Haemonetics' value that differs from its market value or its book value, called intrinsic value, which is Haemonetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Haemonetics' market value can be influenced by many factors that don't directly affect Haemonetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Haemonetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Haemonetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Haemonetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.